MedTrace Logo

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries

NCT05143138 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2025-08-22

Study results available
· View outcomes & findings →

Summary

Multicenter, single-arm retrospective and prospective registry is being conducted to confirm the clinical performance and safety of GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis when used as a Bridging Stent with Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries.

Conditions

  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm

Interventions

DEVICE

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

Patients treated with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis as a Bridging Stent

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Luca Bertoglio, Prof · spedali civili brescia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-23
Primary Completion
2024-04-30
Completion
2026-12-31
FDA Device
Yes

Countries

  • Denmark
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143138 on ClinicalTrials.gov